Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL
Crossref DOI link: https://doi.org/10.1007/s00259-016-3315-7
Published Online: 2016-02-23
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mikhaeel, N. George
Smith, Daniel
Dunn, Joel T.
Phillips, Michael
Møller, Henrik
Fields, Paul A.
Wrench, David
Barrington, Sally F.
License valid from 2016-02-23